Evidence map›Paper›PMID 37035195›Full record

ArticleFrontiers in oncology2023

B cells as modulators of HPV+ oropharyngeal cancer in a preclinical model.

Jorge R Galán-Ortíz, Kamila A Andino Del Valle, Abelardo A Pérez-Rosario, Daniel L Castañón Pereira, Jennifer Díaz-Rivera, Pamela A Merheb-Finianos, Stephanie M Dorta-Estremera

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Jorge R Galán-OrtízCancer Biology Division, Comprehensive Cancer Center, University of Puerto Rico, San Juan, Puerto Rico.
Kamila A Andino Del ValleMicrobiology and Medical Zoology Department, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.
Abelardo A Pérez-RosarioBiology Department, University of Puerto Rico, San Juan, Puerto Rico.
Daniel L Castañón PereiraBiomedical Sciences Department, San Juan Bautista School of Medicine, Caguas, Puerto Rico.
Jennifer Díaz-RiveraMicrobiology and Medical Zoology Department, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.
Pamela A Merheb-FinianosSchool of Medicine, Central University of the Caribbean, Bayamón, Puerto Rico.
Stephanie M Dorta-EstremeraCancer Biology Division, Comprehensive Cancer Center, University of Puerto Rico, San Juan, Puerto Rico.
University of Puerto Rico, Medical Sciences Campus · PRUniversity of Puerto Rico System · PRCentral University of the Caribbean · PRIndiana University Melvin and Bren Simon Comprehensive Cancer CenterSan Juan Bautista School of Medicine · PR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the different immune cells present within tumors, B cells also infiltrate human papillomavirus-positive (HPV+) oropharyngeal tumors. However, the role of B cells during programmed death-1 (PD-1) blockade in HPV+ oropharyngeal cancer needs to be better defined. By using the preclinical mouse model for HPV+ oropharyngeal cancer (named mEER), we characterized B cells within tumors and determined their functional role

Indexed as

B cellscancersHPVoropharyngealPD-1 blockade

Identifiers

PMID37035195
PMCPMC10076859
OpenAlexW4360616593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.